benzinga

3 Biotech Stocks With Rising Short Interest – Benzinga

Related JUNOGene Therapy Stocks Take Beating On Bad News For CelladonCAR-T Therapy Stocks Hit Hard Following AACR DataThe Real Value In MabVax May Be Partnerships Rather Than Pipeline(Seeking Alpha)While short interest in most of the leading biotechs and emerging pharmaceuticals shrank between the March 31 and April 15 settlement dates, three stocks bucked that trend.Juno Therapeutics Inc (NASDAQ: JUNO) and […]

Stock Market Grind Faces Big Tests In Apple, Fed Meeting – Benzinga

After tacking on another 2.5% over the past few weeks, the S&P 500 (SPX) scratched out a fresh record high heading into the final four trading days of April.But another steady drip of earnings reports—kicked off by Apple’s (NASDAQ: AAPL) post-close release on Monday—and the latest glimpse into the mind of the Federal Reserve could potentially test stock rally conviction.Apple’s […]

5 Biotech Stocks Roth Capital Analysts Are Watching – Celldex …

Related CLDXWhy Cowen & Co Likes Celldex Therapeutics Following Its FDA ‘Breakthrough’Biotech Stocks Moving HigherCelldex Therapeutics(Investor’s Business Daily)Related BLRXMorning Market GainersBenzinga’s Top #PreMarket GainersRoth Capital Weighs In On 5 Biotech Stocks To Watch(Seeking Alpha)As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.”Though […]

Short Interest In Semiconductor Stocks Soars – Broadcom …

Related BRCMOppenheimer: 4 Tech Stocks That Are Technical BuysBroadcom: Expect Softening Performance Metrics In 2015, But Company Is Still Well Positioned In The MarketBroadcom Brings New Devices for Cable Operators in China – Analyst Blog(Zacks)Broadcom Corporation (NASDAQ: BRCM), QUALCOMM, Inc. (NASDAQ: QCOM) and Xilinx, Inc. (NASDAQ: XLNX) were among the leading semiconductor stocks that had surges in their short interest […]

Durable-Goods Downer Could Kill Mega-Deal Buzz – Berkshire …

Is there some secret holiday at work in the stock and currency markets that I’m unaware of? Volume is non-existent, with only deal buzz potentially stirring the Street from this spring slumber.Conditions can only be characterized as rail-thin, holiday-like volumes that leave major stock averages teetering just below record highs.In fact, the bond market has rallied for three days in […]

Is Intercept The Next Biotech To Break Out?

View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]

Maxim Sees Major Upside In These Biotech Stocks

In a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as data from a phase II trial of MultiStem treatment one to two […]

Be Your Own Driving Force: Trading In An IRA | Benzinga

When building a retirement portfolio that includes an Individual Retirement Account (IRA), some investors slide over to let the financial professionals take the wheel. They’re okay letting the experts map the course, speed, and risk.Other investors, especially those who trade stocks, and even futures in other types of brokerage accounts, prefer to keep at least one hand on the controls. […]

Barclays Expands Coverage To 7 New Biotech Stocks

Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at Underweight with an $8 price target. The firm’s thesis was that “Achillion is likely to get left behind even with solid clinical data; a takeout may be one of […]

Short Sellers Come Back To Biotech Stocks

View photo.By and large, short interest among the leading biotechs and emerging pharmaceuticals reversed course and rose again between the January 30 and February 13 settlement dates.Leading that trend were Amgen, Inc. (NASDAQ: AMGN), Juno Therapeutics Inc (NASDAQ: JUNO) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Below we take a quick look at how these three stocks have fared recently and what […]